BioScrip Nominates Three New Independent Directors

ELMSFORD, N.Y., Feb. 9, 2015 /PRNewswire/ — BioScrip, Inc. (NASDAQ: BIOS) (the “Company”) today announced that it will nominate David Golding, Michael Goldstein and R. Carter Pate for election to the BioScrip Board of Directors at the Company’s 2015 Annual Meeting of Shareholders (the “Annual Meeting”). Caldwell Partners assisted BioScrip’s Board in the director nominee search process.

Click to read full press release.

Back to Insights

Stay on top of the latest intel across multiple industries and continents.